Samumed raises $438M, plans host of trials

Regenerative medicine company Samumed LLC (San Diego, Calif.) raised $438 million in an equity round that included existing investor Vickers Venture Partners and other undisclosed new and existing investors, including family offices, high net worth individuals and sovereign wealth funds. Samumed said the round came at a premoney valuation of $12 billion.

Existing shareholders contributed 15-20% of the round, with new investors contributing the balance, Samumed CBO Erich Horsley told BioCentury. Horsley acknowledged that the private venture firm of Ikea Group (Leiden, the Netherlands) previously invested in Samumed, but did not disclose whether that investor participated in the new round...